Additionally, chronic treatment with ghrelin agonist HM01 was found to improve 6-OHDA lesion-induced non-motor symptoms in a rat model of PD, including alterations in body weight, fecal weight, food intake, and water consumption (Minalyan et al., 2019). The gene discussed is GHRL; the disease is Parkinson disease.